The lawyer scored a victory, clearing the billionaire's name and paving the way for "many millions of dollars" in attorney ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

Months after causing safety concerns that led the FDA to hit a related trial with a clinical hold, a phase 2 trial of ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

A new era of medical science is taking shape in Massachusetts. Our biotech companies are at work on a gene therapy that can cure deafness, treatments that slow the effects of aging, and a ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Sarcomatrix Therapeutics We are honored to present our progress at Start-Up Stadium and look forward to engaging with investors and partne ...

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

The duality is a hallmark of Greater Boston’s lab market these days. Bright spots surely remain, such as big new lab ...